Managing Your Care: Treatments and Symptom Support

Because Progressive Muscular Atrophy (PMA) is so rare, there are currently no medications that have been tested and approved specifically for it. Instead, the approach often involves using treatments that have been proven effective for ALS and applying them to PMA. This “extrapolation” is based on the growing medical consensus that PMA and ALS are part of the same disease spectrum ^[1][2].

Disease-Modifying Therapies

Your neurologist may discuss “off-label” use of ALS medications. This means the drugs are approved for ALS but may be prescribed for you because of the shared underlying disease process.

• Riluzole: This is the most common medication for motor neuron diseases. In ALS studies, it has been shown to extend survival by approximately 2 to 3 months ^[3]. While there isn’t a PMA-specific study establishing its efficacy, it is often prescribed to PMA patients in hopes of achieving a similar neuroprotective effect. Liver enzymes and side effects require regular monitoring ^[2].
• Edaravone: This is an antioxidant treatment designed to reduce “oxidative stress” in the nerves. It was approved for ALS based on its ability to slow functional decline in a specific group of patients ^[4]. Evidence for its use in PMA is limited, but it may be considered off-label in some clinical settings ^[5].
• Tofersen: This is a specialized “antisense” therapy that targets a specific genetic mutation called SOD1. Depending on your jurisdiction, it is an approved or investigational therapy strictly for confirmed SOD1 mutation-associated ALS ^[6].

The Clinical Trial Barrier

If you have looked for clinical trials, you may have noticed that many exclude people with PMA. This is often because they use the Revised El Escorial criteria, which require visible damage to both upper and lower motor neurons for a patient to qualify ^[7][8].

This is changing. Newer standards, like the Gold Coast criteria, recognize PMA as a form of ALS. This shift may help improve access, though trial eligibility remains protocol-specific and you should review each study’s inclusion rules with the research team ^[9][10].

The Multidisciplinary Care Model

While medications are important, the most effective way to manage PMA symptoms today is through a multidisciplinary care team. This is a group of specialists who work together to address every aspect of your health:

• Physical Therapy (PT): Focuses on keeping you moving safely. They will guide you in submaximal activity and range-of-motion strategies. It is crucial not to exercise to the point of exhaustion, which can worsen fatigue and function. They can also recommend braces (orthoses) to help with “foot drop,” and suggest mobility aids ^[11][12].
• Occupational Therapy (OT): Helps you maintain independence in your daily life. They recommend “adaptive equipment,” such as specialized utensils for eating, button hooks for dressing, or modifications to make your bathroom safer ^[11].
• Speech-Language Pathology (SLP): If the disease begins to affect your “bulbar” muscles (those used for speech and swallowing), an SLP focuses on swallowing-safety and compensatory techniques. They also evaluate your swallowing safety and can introduce Augmentative and Alternative Communication (AAC) devices if speaking becomes difficult ^[11][13].
• Respiratory and Nutritional Care: Your team will regularly check your breathing strength and your weight. If your breathing muscles weaken, they may recommend Non-Invasive Ventilation (NIV)—a mask you wear at night to help you breathe—or a feeding tube (gastrostomy) if swallowing becomes unsafe or if you are losing weight ^[12][11].

Targeted Symptom Management

Your care team can also provide specific treatments for daily symptoms that impact your quality of life. Be sure to report issues such as muscle cramps, pain, excess saliva, constipation, sleep disturbances, fatigue, and mood changes, as well as caregiver strain.

Managing PMA is about more than just a prescription; it is about building a support system that adapts as your needs change ^[14].